首页 > 文献资料库 > 详情

Consensus Recommendations on the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volum

Danny Vleggaar MD, Rebecca Fitzgerald MD, Z. Paul Lorenc MD FACS, J.Todd Andrews MD, Kimberly Butterwick MD, Jody Comstock MD, C. William Hanke MD, T. Gerald O'Daniel MD FACS, Melanie D. Palm MD MBA, Wendy E. Roberts MD, Neil Sadick MD, and Craig F. Tell


你可能喜欢...

09-22

2021

The biological basis for poly-L-lactic acid-induced augmentation

PLLA-induced augmentation is most likely based on capsule formation orchestrating macrophages, (myo-)fibroblasts, and collagen type I and III fibres. We observed considerably slower degradation of PLLA particles than described previously. Thus PLLA partic

08-12

2021

Injection technique in neurotoxins and fillers: Indications, products, and outcomes

Injectable fillers and neuromodulators are used for a range of indications pertaining to the correction of facial aging and disfigurement. Fillers can correct soft tissue loss, depressed scars, and atrophy or asymmetry induced by systemic or local disease

08-12

2021

A Decade of Experience with Injectable Poly-L-Lactic Acid: A Focus on Safety

Important lessons have been learned in the use of injectable PLLA that have helped reduce the frequency of adverse events and make it desirable for restoring facial volume (Table 1). The importance of diffuse distribution of the injectable PLLA suspension